Subscribe To
Here are 3 marijuana stocks for cannabis investors to watch right now
The cannabis industry over the last several years continues to grow and progress. Between more states g...
November 4, 2023, 10:19 am
A good buy rating: travelzoo looks poised for upside
Travelzoo is an internet media company that generates revenue through travel advertising and exclusive deals curated by global experts. The introducti...
November 4, 2023, 7:09 am
Jubilee metals ceo talks progress and prospects - icymi
In conversation with Thomas Warner from Proactive, Leon Coetzer, CEO of Jubilee Metals Group PLC (AIM:JLP, JSE:JBL, OTC:JUBPF), delved into the strat...
November 4, 2023, 6:38 am
Chewy: pharmacy remains a big opportunity, but stock looks fairly valued
Chewy's autoship program is a major strength, with 75.5% of sales coming from autoship customers. The c...
November 4, 2023, 6:19 am
Kefi gold and copper: a comprehensive update on operational progress and market dynamics - icymi
In this interview, Thomas Warner from Proactive chats with Harry Anagnostaras-Adams, the executive chairman of KEFI Gold and Copper PLC (AIM:KEFI, OT...
November 4, 2023, 5:29 am
Xrp news: sec v ripple recap as the november 9 countdown begins
Amid the SEC v Ripple lawsuit, Bill Hinman’s role and the programmatic Sales ruling could take center...
November 4, 2023, 12:58 am
Correction: national youth prevention summit highlights colorado campaign to protect teens from fentanyl
This release has been corrected to identify the source as SE2 Denver, Colo., Nov. 03, 2023 (GLOBE NEWSWIRE) — A national youth prevention summit org...
November 3, 2023, 11:10 pm
Prime medicine reports third quarter 2023 financial results and provides business updates
— Presented new preclinical research across multiple programs, including proof-of-concept data from i...
November 3, 2023, 8:01 pm
Update: korro bio and frequency therapeutics announce closing of merger and private placement of $117 million
Korro will be focused on advancing a wholly owned portfolio of RNA editing programs Post-transaction ca...
November 3, 2023, 7:31 pm
Actinium pharmaceuticals: the trickle down continues, and i maintain a buy
Actinium Pharmaceuticals continues to make progress with their radiolabelled CD45 antibody Iomab-B, whi...
November 3, 2023, 6:08 pm
Cal-soap’s 20th anniversary with live oak injury law group
GILROY, Calif., Nov. 03, 2023 (GLOBE NEWSWIRE) — Attorney Richard E. Eichenbaum, Esq., founder of Live Oak Injury Law Group was pleased to attend as...
November 3, 2023, 6:00 pm
Korro bio and frequency therapeutics announce closing of merger and private placement of $117 million
Korro will be focused on advancing a wholly owned portfolio of RNA editing programs Post-transaction ca...
November 3, 2023, 4:19 pm
4%-yielding southern company is a utility gem
Southern Company's stock has performed well, up over 90% in the past five years, and its recent earnings report showed positive ...
November 3, 2023, 4:17 pm
Podcastone (podc) expands slate of original programming, acquires exclusive rights to vigilante podcast, including ip for tv/ film
Vigilante Named “Best True Crime Podcast” in Its Debut, Over 2 Million Downloads to Date Year to Date PodcastOne Has Added 18 New ...
November 3, 2023, 3:50 pm
Oceana: coca-cola and pepsi’s plastic packaging use increases by hundreds of millions of pounds
Oceana calls on both companies to increase reusable packaging and reduce single-use plastic, after Ellen MacArthur Foundation report reveals significa...
November 3, 2023, 2:06 pm
Coherus presents data from next-generation immuno-oncology programs at 38th annual meeting of society for immunotherapy of cancer (sitc)
– Data demonstrate distinct IL-27-mediated expression of genes associated with immune suppression in vitro, supporting ongoing clinical development ...
November 3, 2023, 12:30 pm
Why redfin stock catapulted higher today
Redfin is making progress toward revenue growth again. The company reported positive adjusted EBITDA in...
November 3, 2023, 12:24 pm
Protara therapeutics announces third quarter 2023 financial results and business update
Dosing is progressing well in ADVANCED-1EXP trial evaluating TARA-002 in NMIBC patients with CIS; preli...
November 3, 2023, 12:00 pm
Galectin therapeutics to share five scientific presentations at the liver meeting™ 2023, hosted by the aasld
Pharmacokinetics and safety of belapectin in patients with hepatic insufficiency Lack of impact of belapectin on cardiac repolarization (QT interval) ...
November 3, 2023, 12:00 pm
Turnstone biologics presents preclinical data highlighting potential for selected tumor-infiltrating lymphocyte (til) therapy in solid tumors at the 2023 society for immunotherapy of cancer (sitc) ann
Presentations showcase Turnstone’s novel Selected TIL programs which are designed to selectively expa...
November 3, 2023, 10:00 am